Steven Radoff

1.8k total citations · 1 hit paper
15 papers, 1.5k citations indexed

About

Steven Radoff is a scholar working on Molecular Biology, Cell Biology and Clinical Biochemistry. According to data from OpenAlex, Steven Radoff has authored 15 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cell Biology and 6 papers in Clinical Biochemistry. Recurrent topics in Steven Radoff's work include Proteoglycans and glycosaminoglycans research (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Advanced Glycation End Products research (6 papers). Steven Radoff is often cited by papers focused on Proteoglycans and glycosaminoglycans research (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Advanced Glycation End Products research (6 papers). Steven Radoff collaborates with scholars based in United States. Steven Radoff's co-authors include Helen Vlassara, Zenji Makita, Anthony Cerami, Edward Y. Skolnik, Martina Kirstein, Zhi Yang, Eli A. Friedman, Vera Delaney, Elliot J. Rayfield and Satoshi Ogawa and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Steven Radoff

15 papers receiving 1.4k citations

Hit Papers

Advanced Glycosylation End Products in Patients with Diab... 1991 2026 2002 2014 1991 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
    1991 740 citations Zenji Makita, Steven Radoff et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Radoff United States 11 1.0k 589 306 264 211 15 1.5k
Tamami Okamoto Japan 15 782 0.8× 390 0.7× 194 0.6× 413 1.6× 159 0.8× 17 1.5k
A.M. Schmidt United States 6 1.3k 1.3× 625 1.1× 177 0.6× 564 2.1× 325 1.5× 6 2.0k
Shinjiro Amano Japan 15 787 0.8× 386 0.7× 190 0.6× 478 1.8× 147 0.7× 20 1.5k
M.-P. Wautier France 17 735 0.7× 411 0.7× 137 0.4× 242 0.9× 407 1.9× 32 1.4k
Tina Soulis Australia 12 720 0.7× 434 0.7× 360 1.2× 220 0.8× 180 0.9× 14 1.2k
Kohachiro Koga Japan 9 571 0.6× 292 0.5× 174 0.6× 217 0.8× 95 0.5× 11 943
Takayuki Higashi Japan 15 785 0.8× 396 0.7× 89 0.3× 216 0.8× 203 1.0× 38 1.3k
Clotilde Zoukourian France 4 525 0.5× 293 0.5× 71 0.2× 124 0.5× 202 1.0× 5 764
Yuko Jinnouchi Japan 14 472 0.5× 233 0.4× 57 0.2× 287 1.1× 116 0.5× 17 989
Yoshiteru Jinnouchi Japan 8 625 0.6× 311 0.5× 60 0.2× 162 0.6× 161 0.8× 12 827

Countries citing papers authored by Steven Radoff

Since Specialization
Citations

This map shows the geographic impact of Steven Radoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Radoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Radoff more than expected).

Fields of papers citing papers by Steven Radoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Radoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Radoff. The network helps show where Steven Radoff may publish in the future.

Co-authorship network of co-authors of Steven Radoff

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Radoff. A scholar is included among the top collaborators of Steven Radoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Radoff. Steven Radoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Makita, Zenji, Steven Radoff, Elliot J. Rayfield, et al.. (1991). Advanced Glycosylation End Products in Patients with Diabetic Nephropathy. New England Journal of Medicine. 325(12). 836–842. 740 indexed citations breakdown →
2.
Skolnik, Edward Y., Zhe Yang, Zenji Makita, et al.. (1991). Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.. The Journal of Experimental Medicine. 174(4). 931–939. 206 indexed citations
3.
Radoff, Steven, Zenji Makita, & Helen Vlassara. (1991). Radioreceptor Assay for Advanced Glycosylation End Products. Diabetes. 40(12). 1731–1738. 25 indexed citations
4.
Radoff, Steven, Anthony Cerami, & Helen Vlassara. (1990). Isolation of Surface Binding Protein Specific for Advanced Glycosylation End Products From Mouse Macrophage-Derived Cell Line RAW 264.7. Diabetes. 39(12). 1510–1518. 53 indexed citations
5.
Radoff, Steven, Anthony Cerami, & Helen Vlassara. (1990). Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7. Diabetes. 39(12). 1510–1518. 13 indexed citations
6.
Kirstein, Martina, J Brett, Steven Radoff, et al.. (1990). Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.. Proceedings of the National Academy of Sciences. 87(22). 9010–9014. 310 indexed citations
7.
Radoff, Steven, Helen Vlassara, & Anthony Cerami. (1988). Characterization of a solubilized cell surface binding protein on macrophages specific for proteins modified nonenzymatically by advanced glycosylated end products. Archives of Biochemistry and Biophysics. 263(2). 418–423. 45 indexed citations
8.
Radoff, Steven, Helen Vlassara, & Anthony Cerami. (1987). Isolation of a macrophage receptor for proteins modified by advanced glycosylation end products. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 1 indexed citations
9.
Radoff, Steven & I. Danishefsky. (1985). Distribution of glucuronic and iduronic acid units in heparin chains.. Journal of Biological Chemistry. 260(28). 15106–15111. 7 indexed citations
10.
Rosenfeld, Louis, Steven Radoff, & I. Danishefsky. (1985). The uronic acid composition of anticoagulantly active and inactive heparin. Archives of Biochemistry and Biophysics. 242(2). 574–578. 5 indexed citations
11.
Radoff, Steven & I. Danishefsky. (1984). Location on heparin of the oligosaccharide section essential for anticoagulant activity.. Journal of Biological Chemistry. 259(1). 166–172. 33 indexed citations
12.
Radoff, Steven & I. Danishefsky. (1982). High-activity heparin: Chain length, affinity for antithrombin, and anticoagulant activity. Archives of Biochemistry and Biophysics. 215(1). 163–170. 20 indexed citations
13.
Radoff, Steven & I. Danishefsky. (1982). Solid-phase synthesis of fluorescent heparin. Analytical Biochemistry. 120(2). 373–378. 10 indexed citations
14.
Radoff, Steven & I. Danishefsky. (1981). Isolation and properties of high molecular weight heparin. Thrombosis Research. 22(3). 353–365. 16 indexed citations
15.
Danishefsky, I., Steven Radoff, Michael L. Bender, & German B. Villanueva. (1979). Isolation and Characteristics of High-Activity Heparin. Thrombosis and Haemostasis. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamami Okamoto Breakdown of academic impact, for papers by A.M. Schmidt Breakdown of academic impact, for papers by Shinjiro Amano Breakdown of academic impact, for papers by M.-P. Wautier Breakdown of academic impact, for papers by Tina Soulis Breakdown of academic impact, for papers by Kohachiro Koga Breakdown of academic impact, for papers by Takayuki Higashi Breakdown of academic impact, for papers by Clotilde Zoukourian Breakdown of academic impact, for papers by Yuko Jinnouchi Breakdown of academic impact, for papers by Yoshiteru Jinnouchi
Rankless by CCL
2026